Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 24, 2015 8:05 PM ET

Pharmaceuticals

Company Overview of Mallinckrodt public limited company

Executive Profile

Mark Christopher Trudeau

Chief Executive Officer, President, Director and Member of Portfolio Committee, Mallinckrodt public limited company
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 4 different industries.

See Board Relationships
53$6,502,676
As of Fiscal Year 2014

Background

Mr. Mark Christopher Trudeau has been Chief Executive Officer and President of Mallinckrodt public limited company since June 2013. Mr. Trudeau was joined Covidien plc as Senior Vice President and President of Pharmaceuticals Segment in February 1, 2012. He was joined Covidien from Bayer HealthCare Pharmaceuticals LLC USA, the U.S. healthcare business of Bayer AG, where he served as Chief Executive Officer. He simultaneously served as President of Bayer HealthCare Pharmaceuticals, ...

Corporate Headquarters

Damastown Industrial Estate
Dublin, Co. Dublin 15

Ireland

Phone: 353 1 880 8180
Fax: --

Board Members Memberships

2013-Present
Trustee
2013-Present
Chief Executive Officer, President, Director and Member of Portfolio Committee

Education

Bachelor's Degree
University of Michigan
MBA
University of Michigan

Other Affiliations

Annual Compensation

Salary$905,769
Total Annual Compensation$905,769

Stocks Options

Restricted Stock Awards$2,208,460
All Other Compensation$98,173
Exercised Options$55,245
Exercised Options Value$790,127
Unexercisable Options$413,280
Unexercisable Options Value$18,740,763
Total Value of Options$19,530,890
Total Number of Options$468,525

Total Compensation

Total Annual Cash Compensation$2,853,942
Total Short Term Compensation$905,769
Other Long Term Compensation$2,306,633
Total Calculated Compensation$6,502,676
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Rajiv Kanishka Liyanaarchchie De Silva Chief Executive Officer, President and Director
Endo International plc
$1.1M
Yves L'epine Chief Executive Officer, Director and Member of Strategy & Innovation Committee
Guerbet SA
$370.8K
Olivier Legrain Chief Executive Officer, President, Director and Member of Nomination Committee
Ion Beam Applications, S.A.
$639.5K
Arthur P. Bedrosian J.D.Chief Executive Officer, Director and Chairman of Strategic Planning Committee
Lannett Company, Inc.
$539.0K
F. Michael Ball Chief Executive Officer, Director and Member of Science & Technology Committee
Hospira Inc.
$1.1M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Mallinckrodt public limited company, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.